Release Date: 24/08/12 18:02 Summary: Cancellation of Shares - ASIC Form 484 Price Sensitive: No Download Document 137.71KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%